Application 202771
- Type
- ANDA
- Sponsor
- MYLAN LABS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | ETHINYL ESTRADIOL; NORETHINDRONE ACETATE | TABLET;ORAL-21 | 0.02MG;1MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-7280 | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | norethindrone acetate and ethinyl estradiol | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-7280 | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | norethindrone acetate and ethinyl estradiol | Mylan Pharmaceuticals Inc. | ANDA | Current |